Dec 2012

Home >> Clinical Trials News Archive >> 2012 >> Dec 2012
A branch of The International Society of Pharmacovigilance (ISoP) is being founded in Israel. “We hope to increase awareness about pharmacovigilance in the local industry and among all stakeholders,” says Dr. Irene Fermont, a founding member and a vice-president of ADDS (Advanced Drug & Device Services).

Does Jerusalem Have What It Takes to Build A Life Sciences Cluster?
Dark news was coming out of Israel on the morning of November 15. But in a talk that morning at MIT, Nir Barkat, mayor of Jerusalem, painted a bright picture of the city’s future. Barkat—whose name, incidentally, means “light”—argues that Jerusalem’s “brand name” has been building for over 3,000 years, writes Fiona Murray in Xconomy. Murray is Faculty Director of the Martin Trust Center for MIT Entrepreneurship and David Sarnoff Professor of Management of Technology at the MIT Sloan School of Management.
 
Attracting international investors to Israel. World is searching for technology and knowledge – and Israel has it on offer. Investment promotion center at Industry, Trade and Labor Ministry connects international investors with Israeli companies or entrepreneurs starting a new venture.

 
Tel Aviv Ranks 2nd on List of Startup-Friendly Cities. A recent report placed Tel Aviv second among the top-twenty friendliest places for tech start-ups in the world. The report was issued by Startup Genome, an impressive online community that has compiled data on more than 50,000 start-ups worldwide.